Quintessential Beecher - Surgery as placebo: A quantitative study of bias. J Am Med Assoc. 1961;176:1102-1107

International Anesthesiology Clinics

Volumn 45, Issue 4, 2007, Pages 47-63

  Podolsky, Scott H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CAUSE OF DEATH; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; NONHUMAN; PATIENT SELECTION; PHYSICIAN ATTITUDE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STUDY; REVIEW; SURGEON; SURGICAL APPROACH; SURGICAL PATIENT;

BIAS (EPIDEMIOLOGY); CARDIOVASCULAR DISEASES; HISTORY, 20TH CENTURY; HUMANS; PLACEBO EFFECT; PLACEBOS; SURGERY; UNITED STATES;

EID: 37349076209     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/AIA.0b013e31812e56ee     Document Type: Review

References (94)

1. Marks HM. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990. New York: Cambridge University Press; 1997:129-163.
2. Kaptchuk TJ. Intentional ignorance: a history of blind assessment and placebo controls in medicine. Bull Hist Med. 1998;72:427-432.
3. As Beecher jotted to himself in 1950: "The measurement of subtle human emotions in reproducible terms is no less of an achievement than that of 'pure' mathematics." In "Thesis: Ideas are More Important than Machines," unpublished note, 10/21/50, Box 25, ff 45, Henry K. Beecher Papers, Countway Medical Library (hereafter HBP). Denton JE, Beecher HK. I. Methods in the clinical evaluation of new analgesics. J Am Med Assoc. 1949;141:1056-1057;
4. Beecher HK. A method for quantifying the intensity of pain. Science. 1953;118:322-324;
5. Beecher HK. Appraisal of drugs intended to alter subjective responses, symptoms. J Am Med Assoc. 1955;158:399-401;
6. Beecher HK. Measurement of Subjective Responses: Quantitative Effects of Drugs. New York: Oxford University Press; 1959.
7. Denton JE, Beecher HK. Methods in the clinical evaluation of new analgesics. 1056; Keats AS, D'Alessandro GL, Beecher HK. A controlled study of pain relief by intravenous procaine. J Am Med Assoc. 1951;147:1761, 1763.
8. Beecher HK. Clinical impression and clinical investigation. J Am Med Assoc. 1953;151:44, 45.
9. Gold H, Kwit NT, Otto H. The xanthines (theobromine and aminophylline) in the treatment of cardiac pain. J Am Med Assoc. 1937;108:2173-2179;
10. Gold H. Cornell conferences on therapy: the use of placebos in therapy. N Y State J Med. 1946;46:1718-1727;
11. Shapiro AK, Shapiro E. The Powerful Placebo: From Ancient Priest to Modern Physician. Baltimore: Johns Hopkins University Press; 1997:141-151.
12. Beecher HK. Resuscitation and sedation of patients with burns which include the airway. Ann Surg. 1943;117:825-833.
13. Beecher HK. Pain in men wounded in battle. Ann Surg. 1946;123:99.
14. Keats AS, Beecher HK. Pain relief with hypnotic doses of barbiturates and a hypothesis. J Pharmacol Exp Ther. 1950;100:11.
15. Beecher HK. The powerful placebo. J Am Med Assoc. 1955;159:1602-1605.
16. Beecher HK. The subjective response and reaction to sensation: the reaction phase as the effective site for drug action. Am J Med. 1956;20:107-113.
17. Beecher HK, Keats AS, Mosteller F, et al. The effectiveness of oral analgesics (morphine, codeine, acetylsalicylic acid) and the problem of placebo 'reactors' and 'non-reactors'. J Pharmacol Exp Ther. 1953;109:393, 399.
18. Lasagna L, Mosteller F, von Felsinger JM, et al. A study of the placebo response. Am J Med. 1954;16:770, 776.
19. Kienle GS, Kiene H. The powerful placebo effect: fact or fiction? J Clin Epidemiol. 1997;50:1311-1318.
20. deCraen AJM, Kaptchuk TJ, Tijssen JGP, et al. Placebos and placebo effects in medicine: historical overview. J R Soc Med. 1999;92:512-513.
21. Michael DeBakey to Henry K. Beecher, 12/30/55, Box 28, ff 53, HBP.
22. Beecher HK. Increased stress and effectiveness of placebos and 'active' drugs. Science. 1960;132:91-92;
23. Evidence for increased effectiveness of placebos with increased stress. Am J Physiol. 1956;187:163-169.
24. Fischer HK, Dlin BM. The dynamics of placebo therapy: a clinical study. Am J Med Sci. 1956;232:511.
25. In discussion following Taber RE and Marchiano T. Observations on the hemodynamic effects of experimental internal mammary artery ligation [original presentation on 11/22/57]. Arch Surg. 1958;76:785.
26. Glover RP, Davila RC, Kyle RH, et al. Ligation of the internal mammary arteries as a means of increasing blood supply to the myocardium. J Thorac Surg. 1957;34:661. "Ischemic heart disease" was not isolated as a subtype of cardiovascular disease (accounting, at the time, for two-thirds of such attributed deaths) until 1968, 5 years after cardiovascular death rates had reached their all-time high. (Death rate, by cause: 1900-1998 [Table Ab929-951].
27. In Carter SB, Gartner SS, Haines MR, Olmstead AL, Sutch R, and Wright G, eds, Historical Statistics of the United States, Earliest Times to the Present: Millennial Edition, Online. New York: Cambridge University Press, 2006).
28. Ellis LB, Blumgart HL, Harken DC, et al. Clinical conference: long-term management of patients with coronary artery disease. Circulation. 1958;17:946.
29. Beck CS. The development of a new blood supply to the heart by operation. Ann Surg. 1935;102:801-813;
30. Vineberg AM. Development of an anastomosis between the coronary vessels and a transplanted internal mammary artery. Can Med Assoc J. 1946;55:117-119.
31. Vineberg A. Coronary vascular anastomoses by internal mammary artery implantation. Can Med Assoc J. 1958;78:871-879;
32. Hardin R, Shumacker HB Jr, Su CS, et al. Bilateral internal mammary artery ligation and coronary artery occlusion. Surg Gynecol Obstet. 1959;108:518-522.
33. Ligation of the internal mammary arteries. N Engl J Med. 1957;257:385.
34. Battezzati M, Tagliaferro A, DeMarchi G. The ligature of the two internal mammary arteries in disorders of vascularization of the myocardium. Minerva Med. 1955;46(part 2):1178-1188.
35. Brill IC, Rosenbaum WM, Rosenbaum EE, et al. Internal mammary ligation. Northwest Med. 1958;57:483
36. (for exceptions, see Blair CR, Roth RF, Zintel HA. Evaluation of internal mammary artery ligation for relief of angina pectoris. Surg Forum. 1957;8:345-348);
37. Adams R. Internal-mammary-artery ligation for coronary insufficiency. N Engl J Med. 1958;258:113-115.
38. Ratcliff JD. New surgery for ailing hearts. Reader's Dig. 1957;71:73.
39. Evans W, Hoyle C. The comparative value of drugs used in the continuous treatment of angina pectoris. Q J Med. 1933;26:311-336;
40. Travell J, Rinzler SH, Bakst H, et al. Comparison of effects of alpha-tocopherol and a matching placebo on chest pain in patients with heart disease. Ann N Y Acad Sci. 1949;52:345-353;
41. Greiner T, Gold H, Cattell M, et al. A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort. Am J Med. 1950;9:143-155;
42. Cole SL, Kaye H, Griffith GC. Assay of anti-anginal agents: I. A curve analysis with multiple control periods. Circulation. 1952;15:405-413.
43. Joseph T. Roberts (Chief of Cardiology at the Veterans Affairs hospital in Buffalo) to Henry K. Beecher, 3/23/57, Box 13, ff 65, HBP. The talk, entitled "Heart Pain: Its Mechanism and Relief," would be the longest of the evening. In Box 13, ff 66, HBP.
44. B.L. Brofman, in discussion following Glover RP, et al. Ligation of the internal mammary arteries, 705. See also Jones DS. Visions of a cure: visualization, clinical trials, and controversies in cardiac therapeutics, 1968-1998. Isis. 2000;91:504-541.
45. Blair CR, Roth RF, Zintel HA. Evaluation of internal mammary artery ligation for relief of angina pectoris. Surg Forum. 1957;8:345-348.
46. Sabiston DC, Blalock A. Experimental ligation of the internal mammary artery and its effect on coronary occlusion. Surgery. 1958;43:906-912.
47. Vansant JH, Muller WH Jr. Experimental evaluation of internal mammary artery ligation as a means of myocardial vascularization. Surgery. 1959;45:840-847.
48. Adams R. Internal-mammary-artery ligation for coronary insufficiency. N Engl J Med. 1958;258:113-115. In a nice (and one imagines, intentional) parallel, Adams also described how a fifth patient, intended for the procedure, had been instead hypnotized out of his pain before the procedure could be undertaken.
49. Kitchell JR, Glover RP, Kyle RH. Bilateral internal mammary artery ligation for angina pectoris: preliminary clinical considerations. Am J Cardiol. 1958;1:46-50.
50. Fish RG, Crymes TP, Lovell MG. Internal-mammary-artery ligation for angina pectoris: its failure to produce relief. N Engl J Med. 1958;259:418.
51. Fremont RE, Klopstock R, Glass P. Controlled studies on the efficacy of bilateral internal mammary artery ligation in patients with angina pectoris. Angiology. 1959;10:20-27.
52. Reported R. Morton Bolman in late 1957: "One of the drawbacks of this procedure, we feel, is that it is too simple. It is an operation that should be done late in the afternoon, when one's colleagues are not present, because it is so simple that they will all be doing it shortly." In discussion following Reference 19. See also Reference 21, p 952.
53. Denman FR, Hampton J. Ligation of the internal mammary arteries. Heart Bull. 1958;7:69.
54. Mazel MS. Evaluation of the bilateral internal mammary artery ligation. Angiology. 1958;9:353-365.
55. Johnson AS, Griffin R. Bilateral internal mammary artery ligation in coronary artery disease: clinical report of thirty cases. J Michigan State Med Soc. 1959;58:84.
56. References 40 and 41 emerged from practitioners who were already performing comparatively more dangerous cardiac surgical procedures for the apparent alleviation of ischemia. See Mazel MS, Bernstein MM, Callen IR, et al. A simple operation for the treatment of chronic coronary artery disease. Arch Surg. 1955;70:309-317.
57. Johnson AS, Griffin R. The Johnson operation for acquired and congenital coronary insufficiency. J Michigan State Med Soc. 1958;57:384-396.
58. In this setting, it is perhaps interesting to note the authors' report that the patients "were told that they would undergo a two-stage procedure (in which the first stage consisted of no arterial ligation) and that some patients derive full benefit from the first stage."
59. Cobb LA, Thomas GI, Dillard DH, et al. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med. 1959;260:1116-1117.
60. See as a later distillation of Beecher's attack on monospecific disease causality, Beecher HK. The placebo effect and sound planning in surgery. Surg Gynecol Obstet. 1962;114:507;
61. and Nonspecific forces surrounding disease and the treatment of disease. J Am Med Assoc. 1962;179:437-440.
62. Dimond EG, Kittle CF, Crockett JE. Comparison of internal mammary artery ligation and sham operation for angina pectoris. Am J Cardiol. 1960;5:483-486.
63. Beecher HK. Surgery as placebo: a quantitative study of bias. J Am Med Assoc. 1961;176:1102-1107.
64. "I am quite certain that this material will precipitate a great deal of controversy." In Henry K. Beecher to F. John Lewis, 10/4/61, Box 29, ff 55, HBP.
65. Beecher HK. Pain, placebos and physicians. Practitioner. 1962;189:141-155.
66. Henry K. Beecher to Richard I. Evans, 8/26/68, Box 29, ff 46, HBP. Beecher also noted to Evans that the paper had been rejected by the American Surgical Association. As Beecher's attention turned to the necessity for the protection of patients under experimental conditions, he continued to turn to the BIMAL studies as justification for the parallel importance of randomized controlled trials, when done properly. See "Vienna," 5/12/65; Henry K. Beecher to Helen Taussig, 8/1/66, both in Box 11, ff 67, HBP.
67. Favolaro RG. Saphenous vein autograft replacement of severe segmental artery occlusion: operative technique. Ann Thorac Surg. 1968;5:334-339.
68. See Reference 30, Jones. This section of the present paper owes a great debt to Jones's paper.
69. Spodick was inspired not by Beecher, but rather by Thomas Chalmers. Chalmers TC. Mortality rate versus funeral rate in clinical medicine. Gastroenterology. 1964;46:788-791.
70. Spodick DH. Letter: need for controlled study. J Am Med Assoc. 1970;213:1344.
71. Spodick DH. The surgical mystique and the double standard. Controlled trials of medical and surgical therapy for cardiac disease: analysis, hypothesis, proposal. Am Heart J. 1973;85:579-583.
72. Spodick DH. Numerators without denominators: there is no FDA for the surgeon. J Am Med Assoc. 1975;232:35-36.
73. Spodick DH. The randomized controlled clinical trial: scientific and ethical bases. Am J Med. 1982;73:420-425.
74. For similar concerns, see Hiatt HH. Lessons of the coronary-bypass debate. N Engl J Med. 1977;297:1462-1464.
75. Spodick DH. Revascularization of the heart - numerators in search of denominators. Am Heart J. 1971;81:149-157.
76. Spodick DH. Letter: coronary revascularization. Circulation. 1971;44:302.
77. McIntosh HD, Garcia JA. The first decade of aortocoronary bypass grafting, 1967-1977. Circulation. 1978;57:419.
78. In 1977, Ernest Barsamian would report on the BIMAL studies: "The opportunity was, indeed, a unique one, as reflected by the fact that no other randomized comparison of an operation with a sham operation has been recorded in the English surgical literature." Barsamian E. The rise and fall of internal mammary artery ligation in the treatment of angina pectoris and the lessons learned. In Bunker JP, Barnes BA, Mosteller F, eds., Costs, Risks, and Benefits of Surgery. New York: Oxford University Press, 1977, p 218.
79. Bonchek LI. Are randomized trials appropriate for evaluating new operations? N Engl J Med. 1979;301:45.
80. In 1973, the University of Michigan's Irwin J. Schatz would ask, amidst a list of such queries about CABG: "Does the relief of pain after bypass surgery occur in more patients than what one might expect from a placebo, or a sham operation?" No answer was forthcoming. Schatz IJ. The need to know, Chest. 1973;63:82.
81. Kolata GB. Coronary bypass surgery: debate over its benefits. Science. 1976;194:1264.
82. Frank JD. The faith that heals. Johns Hopkins Med J. 1975;137:129-130.
83. Heitz A, Crochet D, Lesperance J. Long term improvement of effort angina following aorto-coronary saphenous vein bypass graft surgery: increased myocardial blood flow or pain denial placebo effect? Am J Cardiol. 1976;37:126.
84. Preston TA. Coronary Artery Surgery: A Critical Review. New York: Raven Press; 1977:67-68. Preston would later in the same chapter add: "The methodology of medical science is not wholly applicable to our problem. Therefore, we have the means neither to substantiate nor to disprove the alleged results of coronary artery surgery in a manner satisfactory for definitive answers. If this is the case, we must deal with the problem by the best methods allowable, but we must also admit that these methods do not give us adequate answers."
85. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998;98:2800-2804.
86. Freeman TB, Vawter DE, Leaverton PE, et al. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med. 1999;341:988-992.
87. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol. 2003;54:403-414.
88. Mosely JB, Wray NP, Kuykendall D, et al. Arthroscopic treatment of osteoarthritis of the knee: a prospective, randomized, placebo-controlled study: results of a pilot study. Am J Sports Med. 1996;24:28-34.
89. Mosely JB, O'Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347:81-88.
90. Thomsen J, Bretlau P, Tos M, et al. Placebo effect in surgery for Meniere's disease: a double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol. 1981;107:271-277.
91. Shambaugh GE Jr. Double-blind surgery. Arch Otolaryngol. 1964;79:435-436.
92. Horng S, Miller FG. Is placebo surgery unethical? N Engl J Med. 2002;347:137-139.
93. Kim SYH, Frank S, Holloway R, et al. Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers. Arch Neurol. 2005;62:1357.
94. Miller FG. Sham surgery: an ethical analysis. Am J Bioethics. 2003;3:46.